ChromaCode, Inc has announced the commercial launch of its first-ever multiplex test using their proprietary High Definition Polymerase Chain Reaction (HDPCR™) technology. The HDPCR™ Tick-Borne Pathogen (TBP) Panel is the only multiplex PCR test that detects nine of the most common tick-borne pathogens in a single test.
Testing for tick carrying pathogens is most frequently done using serological assays for a small number of pathogens. Serological tests are challenged by the lack of immune system response in early infections. As a molecular test, HDPCR™ has the potential to allow for early identification of a broader array of pathogens.
HDPCR™ multiplexing technology combines proprietary data science algorithms with widely-used, low-cost chemistries to increase the multiplexing levels of common real-time PCR (qPCR) and digital PCR (dPCR) instruments for simultaneous detection of multiple (5-50) targets in a single reaction. Data are analyzed on the secure ChromaCode Cloud.
ChromaCode’s HDPCR™ TBP panel is the first multiplex PCR test capable of detecting the most common tick-borne pathogens from whole blood specimens in under four hours. Key features of the TBP Panel include a 3x increase in qPCR multiplexing, seamless integration onto common qPCR instrumentation, scalable throughput, and streamlined data analysis, management, and test customization with the ChromaCode Cloud software.
This product is for research use only (RUO). Learn more about ChromaCode’s new HDPCR™ TBP (RUO) Panel by visiting www.chromacode.com/products/hdpcr-tick-borne-pathogen-tbp-panel.
